Related Experiment Videos
Suppression of gonadotrophin secretion does not reverse premature ovarian failure
British Journal of Obstetrics and Gynaecology
|July 1, 1989
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The risk of venous thrombosis in women over 50 years old using oral contraception or postmenopausal hormone therapy.
Journal of thrombosis and haemostasis : JTH·2012
Sex hormone-binding globulin levels are not causally related to venous thrombosis risk in women not using hormonal contraceptives.
Journal of thrombosis and haemostasis : JTH·2012
Risk of borderline and invasive ovarian tumours after ovarian stimulation for in vitro fertilization in a large Dutch cohort.
Human reproduction (Oxford, England)·2011
PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis.
Human reproduction update·2011
Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event.
Journal of thrombosis and haemostasis : JTH·2010
The effect of labour and maternal oxytocin infusion on fetal plasma oxytocin concentration.
British journal of obstetrics and gynaecology·1999
Inconsistencies in classification by experts of cardiotocograms and subsequent clinical decision.
British journal of obstetrics and gynaecology·1999
Serum markers for Down's syndrome in women who have had in vitro fertilisation: implications for antenatal screening.
British journal of obstetrics and gynaecology·1999
Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity.
British journal of obstetrics and gynaecology·1999
Isolated fetal echogenic intracardiac foci or golf balls: is karyotyping for Down's syndrome indicated?
British journal of obstetrics and gynaecology·1999
Second trimester prenatal screening for Down's syndrome using alpha-fetoprotein and free beta hCG: a seven year review.
British journal of obstetrics and gynaecology·1999
Follicular lymphoma and the microenvironment: potential targets and biomarkers.
Expert review of clinical immunology·2026
Targeting the HEC1-NEK2 Axis Suppresses DLBCL Progression and Overcomes Vincristine Resistance.
Molecular cancer therapeutics·2026
Bufalin Inhibits Melanoma Progression and Endothelial Angiogenic Phenotypes via AKT Signaling.
Cancer reports (Hoboken, N.J.)·2026